Free Trial

Gilead Sciences (GILD) SEC Filings & 10K Form

Gilead Sciences logo
$111.89 +0.61 (+0.55%)
Closing price 04:00 PM Eastern
Extended Trading
$109.98 -1.91 (-1.71%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Gilead Sciences SEC Filings

DateFilerForm TypeView
03/27/2025
3:30 PM
Gilead Sciences (Filer)
Form DEF 14A
03/27/2025
3:31 PM
Gilead Sciences (Filer)
Form DEFA14A
03/27/2025
3:32 PM
Gilead Sciences (Filer)
Form ARS
03/20/2025
4:42 PM
Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:32 PM
Gilead Sciences (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
03/18/2025
3:37 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:16 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
6:08 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:12 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:15 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:41 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:04 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:10 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:42 PM
Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
02/19/2025
3:43 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
8:13 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:22 PM
Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:14 PM
Gilead Sciences (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/06/2025
3:24 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:11 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:09 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:15 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
4:47 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
2:31 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:18 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
2:46 PM
GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
01/03/2025
5:33 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2025
5:38 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:17 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
12/23/2024
7:26 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:15 PM
Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
12/19/2024
3:19 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:27 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:22 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:48 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:51 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:24 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:05 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
12/11/2024
6:13 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
1:43 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:10 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
1:35 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:14 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:15 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:31 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
3:15 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:13 PM
Gilead Sciences (Subject)
Form FWP
11/13/2024
8:02 AM
Gilead Sciences (Filer)
Form 424B5
11/06/2024
3:19 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:07 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:09 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:09 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:58 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
6:07 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:43 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:45 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:30 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:33 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:38 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:41 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:20 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
2:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
1:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:17 PM
Gilead Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
4:28 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
8:01 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:06 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:31 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:35 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
06/11/2024
6:12 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:15 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:20 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:23 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:25 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:57 PM
BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:16 PM
Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:23 PM
Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:26 PM
Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:30 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:08 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
8:29 PM
GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
04/19/2024
3:31 PM
Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SC 13G
04/05/2024
3:31 PM
Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
Form SC 13G
04/03/2024
5:48 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
04/03/2024
5:50 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:GILD) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners